+972548034532 info@resultmed.com
Israeli medical cardiology news

 

Cardiology News

 

 

 

 

New guidelines for diabetes and cardiovascular disease. (15/09/2019)

Praluent (alirocumab) reduces mortality for atherosclerotic cardiovascular diseases (ASCVD). (23/04/2019)

Optimizer Smart – an innovative device for the treatment of chronic cardiac insufficiency. (08/04/2019)

A new technology could be a lifesaver for individuals with heart failure awaiting transplant

 

 

All news

Diagnosis of heart diseases

Treatment of heart disease

Leading cardiologists and cardiac surgeons

 

 

DEAR SITE VISITORS, PLEASE NOTE!

ResultMed provides medical treatment organization and coordination services for foreign patients only.

 

       !מבקרים באתר היקרים, אנא שימו לב

.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד


 

For foreign patients:

 

Viber, WhatsApp, Telegram + 972 54 803 45 32

 


 

Are you a foreign patient? Please send your request

New guidelines for diabetes and cardiovascular disease

New European manuals 2019 of ESC and EASD for management and prevention of cardiovascular disease with metformin, SGLT2 adn GLP-1

Two large European organizations – the European Cardiology Society (ESC) in collaboration with the European Association for the Study of Diabetes  (EASD) – have released a new guidelines for patients with diabetes or prediabetic diseases related to the use of new drugs and the prevention of cardiovascular disease (CVD). The recommendations were presented at ESC Congress, and were also published in the European Heart Journal.

Read More

Praluent (alirocumab) reduces mortality for atherosclerotic cardiovascular diseases (ASCVD)

Praluent for reduce cardiovascular risk in adults with ASCVD

Praluent is the only PCSK9- inhibitor approved in EU. The collected data indicate a mortality decrease in cardiovascular diseases.

Read More

Optimizer Smart – breakthrough device for the treatment of cardiac insufficiency

Israeli medical cardiology news

On March 21, 2019, the FDA approved an innovative device  – Smart Optimizer System for treating patients with moderate to severe chronic cardiac insufficiency (CHF) with CCM technology.

Read More